Board of Directors


Rob Neville

Rob is one of the founders of Savara and has served as CEO and President for 6 years. He has recently joined the board of the Cystic Fibrosis Foundation – Central Texas Chapter, a non-profit foundation focused on the treatment and cure of CF. Prior to Savara, Mr. Neville was founder and CEO of the Austin Technology Incubator-based Evity, Inc., which was acquired by BMC in 2000. Based on his work at Evity, Mr. Neville was honored as a finalist for the Ernst & Young Entrepreneur of the Year award. He later founded the management consulting company Clockwise Consulting. Clockwise partnered with local biotech companies, the Texas Children’s Hospital and the Baylor College of Medicine in Houston to develop an ICU-based monitoring and diagnostic device. Mr. Neville holds a post-graduate Engineering degree from the University of Natal South Africa.

Nevan Elam

Nevan Elam – Former Head of Nektar Pulmonary

Mr. Elam is a former member of the executive management team of Nektar Therapeutics where he served as Senior Vice President of the Pulmonary Business Unit. In this role, he oversaw all pulmonary business including research and development, manufacturing and strategic partnerships. Mr. Elam was responsible for the sale of Nektar’s pulmonary business to Novartis for $115 million in 2008.

Richard Hawkins

Richard J Hawkins – Chairman & CEO at id2 Innovations in Drug Development

Mr. Hawkins founded Pharmaco in 1983 and as Chairman, President and Chief Executive Officer, he facilitated the growth of the company to over 700 employees. Pharmaco eventually became PPD Pharmaco, one of the largest clinical contract research organizations in the world. After Pharmco, Mr. Hawkins has served in various capacities in numerous startup companies, including Sensus Drug Development Corporation, which was sold to Pfizer, Covance Biotechnology Services, which was sold to Akzo Nobel and LoopOne, which was sold to Neopost. He currently serves as a Director of SciClone Pharmaceuticals and Cytori Therapeutics. Most recently, he co-founded and acted as President, CEO and Chairman of Austin-based LabNow.


Yuri Pikover

Mr. Pikover is a Managing Director of 37 Technology Ventures, a boutique venture fund focusing on growing early-stage startups, and serves on boards of various companies. From 1993-2008 Mr. Pikover founded and held executive roles in Xylan, Access360, 5square, Folsom Lake Nissan, and served on boards of several dozen companies. Prior to 1993 Mr. Pikover held technical and management positions with Micom Systems and Fibermux Corporation.


Joseph S. McCracken, DVM

Dr. McCracken has more than 25 years of experience in technical, business development and market development roles with biotechnology and pharmaceutical companies. Most recently he was Global Head for Business Development & Licensing at Roche Pharma, where he was responsible for Roche Pharma’s global in-licensing and out-licensing activities. Prior to joining Roche Pharma, Dr. McCracken held the position of Vice President, Business Development at Genentech for more than 10 years.